Compare HBCP & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HBCP | LAB |
|---|---|---|
| Founded | 1908 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.8M | 488.4M |
| IPO Year | 2008 | 2008 |
| Metric | HBCP | LAB |
|---|---|---|
| Price | $59.23 | $0.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $63.50 | $1.35 |
| AVG Volume (30 Days) | 55.3K | ★ 2.3M |
| Earning Date | 04-27-2026 | 05-18-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | 29.01 | ★ 44.68 |
| EPS | ★ 5.87 | N/A |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.74 | $2.63 |
| P/E Ratio | $9.90 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.10 | $0.92 |
| 52 Week High | $64.17 | $1.72 |
| Indicator | HBCP | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 23.71 |
| Support Level | $56.90 | N/A |
| Resistance Level | $61.18 | $1.41 |
| Average True Range (ATR) | 2.05 | 0.07 |
| MACD | -0.26 | -0.01 |
| Stochastic Oscillator | 38.81 | 2.75 |
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.